Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?

Seminars in Hematology

Volumn 37, Issue 1, 2000, Pages 15-29

  Barrett, John ^a,b   Saunthararajah, Yogen ^a,b   Molldrem, Jeffrey ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033973769     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90027-1     Document Type: Article

References (96)

1. Anan K, Ito M, Misawa M, et al: Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen-receptor (HUMARA) gene. Br J Haematol 89:838-844, 1995
2. Appelbaum FR, Barrall J, Storb R, et al: Clonal cytogenetic abnormality in a patient with otherwise typical aplastic anemia. Exp Hematol 15:1134-1139, 1989
3. Asano H, Ohashi H, Ichihara M, et al: Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood 84:588-594, 1994
4. Asano H, Ohashi H, Kinoshita K, et al: Nonclonal hematopoietic progenitor cells in bone marrow of patients with myelodysplastic syndrome, in Nomura T, Yoshida Y (eds): Myelodysplastic Syndromes: Advances in Research and Treatment. Amsterdam, The Netherlands, Elsevier Science, 1995, pp 129-134
5. Ascensão J, Pahwa R, Kagan W, et al: Inhibition of bone marrow colony growth by antilymphocyte globulin. Lancet 1:669-672, 1976
6. Bennett JM, Catovsky DG, Flandrin DAG, et al: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199, 1982
7. Biesma DH, Van den Tweel JG, Verdonck LF, et al: Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 79:1548-1551, 1997
8. Bose S, Deininger M, Gora-Tybor J, Goldman JM, et al: The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 92:3362-3367, 1998
9. Bouscary D, De Vos J, Guesnu M, et al: Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia 11:839-845, 1997
10. Brodsky RA, Sensenbrenner LL, Jones RL: Complete remission in severe aplastic anemia after cyclophosphamide without bone marrow transplantation. Blood 87:491-494, 1996
11. Carella A, Dejana A, Lerma E, et al: In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia. Br J Haematol 95:127-130, 1996
12. Carlo-Stella C, Cazzola M, Bergamaschi G, et al: Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony stimulating factor. Leukemia 3:363-366, 1989
13. Dan K, An E, Futaki M, et al: Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Acta Hematol 89:113-118, 1993
14. De Planque MM, van Krieken JHJM, Kluin-Nelemans HC, et al: Bone marrow histopathology of patients with severe aplastic anemia before treatment and at follow-up. Br J Haematol 72:439-444, 1989
15. Dunn DE, Tanawattacharoen P, Boccuni P, et al: Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 131:401-408, 1999
16. Elghetany MT, Hudnall SD, Gardner FH, et al: Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: An additional tool for differential diagnosis. Haematologica 82:21-24, 1997
17. Flores-Figueroa E, Gutierrez-Espindola G, Guerrero-Rivera S, et al: Hematopoietic progenitor cells from patients with myelodysplastic syndromes: In vitro colony growth and long-term proliferation. Leuk Res 23:385-394, 1999
18. Fohlmeister I, Fischer R, Modder B, et al: Aplastic anemia and the hypocellular myelodysplastic syndrome: Histomorphological, diagnostic and prognostic features. J Clin Pathol 38:1218-1224, 1985
19. Frickhofen N, Kaltwasser JP, Schretzenmeier H, et al: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 324:1297-1304, 1991
20. Frisch B, Lewis SM: The bone marrow in aplastic anemia: Diagnostic and prognostic features. J Clin Pathol 27:231-241, 1974
21. Fuchs D, Denz HA, Nachbauer D, et al: Circulating gamma-interferon in patients with aplastic anemia. Blood 73:858-859, 1989
22. Geissler K, Hinterberger W, Jager U, et al: Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes. Blut 57:45-49, 1988
23. Gersuk GM, Beckham C, Ioken MR, et al: A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 103:176-188, 1998
24. Gluckman E, Devergie A, Faille A, et al: Treatment of severe aplastic anemia with antilymphocyte globulin and androgens. Exp Hematol 6:679-686, 1978
25. Gluckman E, Esperou-Bourdeau H, Baruchel A, et al: Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood 79:2540-2546, 1992
26. Greenberg PL, Cox C, Le Beau M, et al: International survival score for evaluating prognosis in MDS. Blood 89:2079-2088, 1997
27. Harstock RJ, Smith EB, Petty CS: Normal variations with ageing of the amount of hematopoietic tissue in bone marrow from the ilica crest. Am J Clin Pathol 43:326-331, 1965
28. Herrmann F, Griffin JD, Meuer SG, et al: Establishment of an interleukin 2-dependent T cell line derived from a patient with severe aplastic anemia, which inhibits in vitro hematopoiesis. J Immunol 136:1629-1634, 1986
29. Horikawa K, Nakakuma H, Kawaguchi T, et al: Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood 90:2716-2722, 1997
30. Hotta T: Clonality in hematopoietic disorders. Int J Hematol 66:403-412, 1997
31. Hsu HC, Tsai WJH, Chen LY, et al: Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia. Exp Hematol 24:31-36, 1996
32. Imai Y, Fukuoka T, Nakatani A, et al: Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolone. Br J Haematol 93:146-150, 1996
33. Ito T, Ohashi H, Kagami Y, et al: Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndrome following successful chemotherapy. Leukemia 8:839-843, 1994
34. Iwanga M, Furukawa K, Amenomori T, et al: Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Br J Haematol 102:465-474, 1998
35. Jonas̃ova A, Neuwirtova R, Cermak J, et al: Cydosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 100:304-309, 1998
36. Jotterand M, Parlier V: Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes. Leuk Lymphoma 23:253-266, 1996
37. Kearney L: The impact of the new FISH technologies on the cytogenetics of hematological malignancies. Br J Haematol 104:648-658, 1999
38. Kearns WG, Liu J, Aridgides L, et al: Genomic instability in bone marrow failure syndromes: High frequency of aneuploidy by fluorescence in situ hybridization and identification of a spindle checkpoint gene mutation. Blood 1999 (suppl 1, abstr) (in press)
39. Kitagawa M, Saito I, Kuwata T, et al: Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 11:2049-2054, 1997
40. Kouides PA, Bennett JM: Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 33:95-110, 1996
41. Kourilsky P, Claverie JM: MHC-antigen interaction: What does the T cell receptor see? Adv Immunol 45:107-115, 1989
42. Kuriyama K, Tomonaga M, Matsuo T, et al: Diagnostic significance of detecting pseudo Pelger-Huet anomalies and micromegakaryocytes in myelodysplastic syndrome. Br J Haematol 63:665-671, 1986
43. Leeksma OC, Thomas LL, van der Lelie J, et al: Effectiveness of low dose cyclosporine in acquired aplastic anaemia with severe neutropenia. Neth J Med 41:143-148, 1992
44. Lepelley P, Grardel N, Erny O, et al: Fas/APO-1 (CD95) expression in myelodysplastic syndromes. Leuk Lymphoma 30:307-312, 1998
45. Maciejewski JR Anderson S, Katevas P, et al: Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 87:227-234, 1994
46. Maciejewski JP, Selleri C, Cato T, et al: A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture initiating cells) in acquired aplastic anemia. Blood 88:1983-1991, 1996
47. + cells of patients with aplastic anaemia. Br J Haematol 91:245-252, 1995
48. Maciejewski JP, Hibbs JR, Anderson S, et al: Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 22:1102-1110, 1994
49. Mangi MH, Mufti GJ: Primary myelodysplastic syndromes: Diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 79:198-205, 1992
50. Manz CY, Dietrich PY, Schnuriger V, et al: T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia. Blood Cells Mol Dis 23:110-122, 1997
51. Maschek H, Georgii A, Kaloutsi V, et al: Myelofibrosis in primary myelodysplastic syndromes: A retrospective study of 352 patients. Eur J Haematol 48:208-214, 1992
52. Maschek H, Kalousti V, Rodriguez-Kaiser M, et al: Hypoplastic myelodysplastic syndrome: Incidence, morphology, cytogenetics, and prognosis. Ann Hematol 66:117-122, 1993
53. Mathé G, Amiel JL, Schwartzenberg L, et al: Bone marrow graft in man after conditioning by antilymphocyte serum. Br Med J 2:131-136, 1970
54. Mecucci C, Rege-Cambrin G, Michaux JL, et al: Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease. Br J Haematol 64:699-706, 1986
55. Mehta J, Singhal S, Mehta BC, et al: Low-dose cyclosporin for severe aplastic anemia. Am J Hematol 40:73-77, 1992
56. Melenhorst JJ, Fibbe WE, Struyk L, et al: Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia. Br J Haematol 96:85-91, 1997
57. Mikhailova N, Sessarego M, Fugazza G, et al: Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 81:418-22, 1996
58. + T cells in a patient with aplastic anemia. J Clin Invest 87:1567-1574, 1991
59. Molldrem JJ, Caples M, Mavroudis D, et al: Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 99:699-705, 1997
60. Molldrem JJ, Jiang YZ, Stetler-Stevenson MA, et al: Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor V beta profiles. Br J Haematol 102:1314-1322, 1998
61. Najean Y. Anemies aplastiques, in Breton-Gorius J, Reyes F, Rochant H, et al (eds): L'Hematologie de Bernard Dreyfus. Paris, France, Flammarion, 1992, pp 705-721
62. + T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia. Exp Hematol 23:433-438, 1995
63. Nand S, Goodwin JE: Hypoplastic myelodysplastic syndrome. Cancer 62:958-964, 1988
64. Narayanan MN, Geary CG, Freemont AJ, et al: Long-term follow-up of aplastic anaemia. Br J Haematol 86:837-43, 1994
65. Negendank W, Weissman D, Bey TM, et al: Evidence for clonal disease by magnetic resonance imaging in patients with hypoplastic marrow disorders. Blood 78:2872-2879, 1991
66. Nisticò A, Young NS: Gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 120:463-469, 1994
67. Ohno Y, Takahashi Y, Yoshida Y: Ferrokinetics and bone marrow scanning in patients with myelodysplastic syndrome, hypolastic myelodysplastic syndrome and aplastic anemia. (in Japanese) Rinsho Ketsueki 34:260-264, 1993
68. Orazi A, Albitar M, Heerema NA, et al: Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am J Clin Pathol 107:268-274, 1997
69. Piedras J, Hernandez G, Lopez-Karpovitch X: Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes. Am J Hematol 57:113-118, 1998
70. Raghavachar A, Janssen JW, Schretzenmeier H, et al: Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia. Blood 86:2938-2947, 1995
71. Rosenfeld SJ, Kimball J, Vining D, et al: Intensive immunosuppression with antithymocyte globulin and cyclosporine for severe acquired aplastic anemia. Blood 85:3058-3065, 1995
72. Sato T, Kim S, Selleri C, et al: Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. Leukemia 12:1187-1194, 1998
73. Saunthararajah Y, Caples M, Barrett: AJ: ATG induced complete remission in a case of MDS/leukemia. Blood 92:245b, 1998 (suppl 1, abstr)
74. Schretzenmeier H, Jenal M, Herrmann F, et al: Quantitative analysis of cobblestone area-forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay. Blood 88:4474-4480, 1996
75. Schultz JC, Shahidi NT: Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol 45:32-38, 1994
76. Smith MA, Smith JG: The occurrence subtype and significance of hemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. Leuk Res 5:597-601, 1991
77. Socié G: Could aplastic anaemia be considered a pre-preleukaemic disorder? Eur J Haematol 60:60-63, 1996 (suppl)
78. Stoppa AM, Vey N, Sainty D, et al: Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: Absence of eradication of the PNH clone and dependence of response on cyclosporin A administration. Br J Haematol 93:42-44, 1996
79. Stryckmans PA, Dumont JP, Velu T, et al: Cyclosporine in refractory severe aplastic anemia. N Engl J Med 310:655-656, 1984
80. Sugarawa T, Endo K, Shishido T, et al: T-cell mediated inhibition of erythropoiesis in myelodysplastic syndromes. Am J Hematol 41:304-305, 1992
81. Tamai Y, Takami H, Nakahata R, et al: Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes. (in Japanese) Rinsho Ketsueki 38:1243-1248, 1997
82. Tichelli A, Gratwohl A, Wuersch A, et al: Antilymphocyte globulin for myelodysplastic syndrome? Br J Haematol 68:139-140, 1988
83. Tichelli A, Gratwohl A, Nissen C, et al: Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin. Blood 80:337-345, 1992
84. Tricot G, De Wolf-Peeters C, Vlietinck R, et al: Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol 58:217-225, 1984
85. Tsuge I, Kojima S, Matsuoka H, et al: Clonal haematopoiesis in children with acquired aplastic anaemia. Br J Haematol 84:137-143, 1993
86. Tuzuner N, Bennett JM: Reference standards for bone marrow cellularity. Leuk Res 18:645-646, 1994
87. Tuzuner N, Cox C, Rowe JM, et al: Hypocellular MDS: New proposals. Br J Haematol 91:612-617, 1995
88. Van der Schoot CE, Hiuzinger TWJ, Van't Veer-Korthof ET, et al: Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorimeytric assay. Blood 76:1853-1859, 1990
89. van Kamp H, Landegent JE, Jansen RP, et al: Clonal hematopoiesis in patients with acquired aplastic anemia. Blood 78:3209-3214, 1991
90. van Kamp H, Landegent JE, Jansen RP, et al: Myelodysplasia following paroxysmal nocturnal haemoglobinuria: Evidence for the emergence of a separate clone. Br J Haematol 87:399-400, 1994
91. Ueda H, Tashiro S, Kojima S, et al: Instability of chromosome 7 in colony forming cells of patients with aplastic anemia. Int J Hematol 70:13-19, 1999
92. Watari K, Asano S, Shirafuji N, et al: Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73:117-122, 1989
93. Young NS: The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood 79:1385-1392, 1992
94. Young N, Griffith P, Brittain E, et al: A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 72:1861-1869, 1988
95. Young NS, Barrett AJ: Perspective: The treatment of severe acquired aplastic anemia. Blood 85:3367-3377, 1995
96. Young NS, Maciejewski J: The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-12372, 1997